Use of radioguided surgery technique for the treatment of thyroid cancer recurrence: clinical, surgical and anatomopathological aspects
Dhara Giovanna Santin de Souza, Jalmir Rogerio Aust, Rafael Nunes Goulart, Silvia MacDonald Noronha, Fabiana Oenning da Gama, Daniel Knabben Ortellado
Abstract
Introduction: Surgery is the treatment of choice in locoregional thyroid neoplasia recurrence. The intense tissue healing process observed after surgery changes the neck anatomy, makes reoperation difficult, and interferes with surgical success. The use of the Radioguided Occult Lesion Localization (ROLL) technique has become a viable option to localize thyroid tumors. Objective: To analyze the use of the ROLL technique for the treatment of thyroid cancer recurrence with respect to its clinical, surgical and anatomopathological aspects. Methods: A descriptive cross-sectional study that analyzed 56 medical records and anatomopathological examinations of patients of both sexes who had thyroid neoplasms, underwent previous surgeries on this topography, and were submitted to the ROLL technique for recurrence removal from March 2011 to March 2019. Results: Most patients were women aged 46.05 years, on average. Papillary thyroid neoplasm was the most prevalent histological finding. In 100% of the cases, application of the ROLL technique identified and removed the lesions marked with suspicion for malignancy. Conclusion: Radioguided surgery has proved to be a very effective and safe tool to assist with lesion localization for the treatment of thyroid cancer recurrence. This technique has brought no additional side effects to patients, required minimal radiation and made surgery less invasive, reducing postoperative complication rates.
Keywords
References
1. Bluemel C, Herrmann K, Wolf G, Castagnola G, Bellotti C. Radioguided surgery of thyroid carcinoma recurrences. In: Herrmann K, Nieweg OE, Povoski SP, eds. Radioguided surgery. USA: Springer; 2016. p. 209-24. http://dx.doi.org/10.1007/978-3-319-26051-8_14.m
2. Haugen BR. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017;123(3):372-81. http://dx.doi.org/10.1002/cncr.30360. PMid:27741354.m
3. Brassard M, Borget I, Edet-Sanson A, Giraudet L, Mundler O, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Toubert ME, Torlontano M, Benhamou E, Schlumberger M, THYRDIAG Working Group. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab. 2011;96(5):1352-9. http://dx.doi.org/10.1210/jc.2010-2708. PMid:21389143.m
4. Rios A, Rodriguez M, Ferri B, Matínez-Barba E, Febrero B, Parrilla P. Are prognostic scoring systems of value in patients with follicular thyroid carcinoma? Eur J Endocrinol. 2013;169(6):821-7. http://dx.doi.org/10.1530/EJE-13-0372. PMid:24050927.m
5. Ríos A, Rodríguez JM, Parrilla P. Treatment of thyroid follicular carcinoma. Cir Esp. 2015;93(10):611-8. http://dx.doi.org/10.1016/j.ciresp.2015.06.004. PMid:26412746.m
6. Ríos A, Rodríguez JM, Ferri B, Martínez-Barba E, Torregrosa NM, Parrilla P. Prognostic factors of follicular thyroid carcinoma. Endocrinol Nutr. 2015;62(1):11-8. http://dx.doi.org/10.1016/j.endonu.2014.06.006. PMid:25156926.m
7. Rubello D, Pelizzo R, Casara D, Piotto A, Toniato A, Fig L, Gross M. Radio-guided surgery for non-131I-avid thyroid cancer. Thyroid. 2006;16(11):1105-11. http://dx.doi.org/10.1089/thy.2006.16.1105. PMid:17123337.m
8. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg. 2004;130(10):1214-6. http://dx.doi.org/10.1001/archotol.130.10.1214. PMid:15492172.m
9. Gulcelik MA, Karaman N, Dogan L, Sahiner I, Akgul G, Kahraman S, Vural GU. Radioguided occult lesion localization for locally recurrent thyroid carcinoma. Eur Arch Otorhinolaryngol. 2017;274(7):2915-9. http://dx.doi.org/10.1007/s00405-017-4563-2. PMid:28409262.m
10. Tükenmez M, Erbil Y, Barbaros U, Dural C, Salmaslioglu A, Aksoy D, Mudun A, Ozarmağan S. Radio‐guided nonpalpable metastatic lymph node localization in patients with recurrent thyroid cancer. J Surg Oncol. 2007;96(6):534-8. http://dx.doi.org/10.1002/jso.20873. PMid:17680637.m
11. Pouw B, Peeters M-JTFDV, Valdés Olmos RA. Radioguided Surgery of Non-palpable Breast Lesions: Radio Occult Lesion Localization (ROLL). In: Herrmann K, Nieweg OE, Povoski SP, eds. Radioguided surgery. USA: Springer; 2016. p. 139-8. http://dx.doi.org/10.1007/978-3-319-26051-8_9.m
12. Instituto Nacional de Câncer. Câncer de tireoide [Internet]. Rio de Janeiro: INCA; 2018 [cited 2018 Aug 22]. Available from: http://www.inca.gov.br/m
13. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today [Internet]. Lyon, France: International Agency for Research on Cancer; 2018 [cited 2018 Sep 22]. Available from: https://gco.iarc.fr/todaym
14. Borsò E, Grosso M, Boni G, Manca G, Bianchi P, Puccini M, Arganini M, Cabria M, Piccardo A, Arlandini A, Orlandini C, Mariani G. Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results. Q J Nucl Med Mol Imaging. 2013;57(4):401-11. PMid:24322795.m
15. Martino A, Monaco L, Golia R, Miletto P, Capasso P, Lombardi C, De Chiara G, Iannace C, Basagni C, Caracciolo F. A new radioguided procedure for localization and surgical treatment of neck node metastasis of papillary thyroid cancer. J Endocrinol Invest. 2010;33(5):339-42. http://dx.doi.org/10.1007/BF03346596. PMid:20061783.m
16. Ilgan S. Management of recurrent lymph nodes in central and lateral neck in the follow-up of differentiated thyroid carcinoma. In Özülker T, Adaş M, Günay S. Thyroid and parathyroid diseases. USA: Springer; 2019. p. 305-11. http://dx.doi.org/10.1007/978-3-319-78476-2_48.m
17. Erbil Y, Sarı S, Ağcaoğlu O, Ersöz F, Bayraktar A, Salmaslıoğlu A, Gozkun O, Adalet I, Ozarmağan S. Radio-guided excision of metastatic lymph nodes in thyroid carcinoma: a safe technique for previously operated neck compartments. World J Surg. 2010;34(11):2581-8. http://dx.doi.org/10.1007/s00268-010-0714-y. PMid:20632005.m
18. Tuncel M, Süslü N. Radioguided occult lesion localization in patients with recurrent thyroid cancer. Eur Arch Otorhinolaryngol. 2019;276(6):1757-66. http://dx.doi. org/10.1007/s00405-019-05377-w. PMid:30887167.m
19. Giles YŞ, Sarıcı İS, Tunca F, Sormaz İC, Salmaslıoğlu A, Adalet I, Özgür İ, Tezelman S, Terzioğlu T. The rate of operative success achieved with radioguided occult lesion localization and intraoperative ultrasonography in patients with recurrent papillary thyroid cancer. Surgery. 2014;156(5):1116-26. http://dx.doi.org/10.1016/j.surg.2014.04.012. PMid:24953276.m
20. Matos FC, Vasconcellos S, Melo BC Jr, Amaral F. Agulhamento pré operatório guiado por ultrassonografia no tratamento de recidivas linfonodais de carcinoma diferenciado de tireoide. Rev Bras Cir Cabeça Pescoço. 2012;41(2):65-9.m
21. Cavallieri SA, Kligerman J, Cavallieri FA, Conti CD, Gomes CFA. Marcação préoperatória com carvão nas metástases linfonodais não palpáveis da região cervical, guiada pela ultrassonografia. Rev Bras Cir Cabeça Pescoço. 2013;42(2):83-7.m
22. Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR, British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Suppl 1):1-122. http://dx.doi.org/10.1111/cen.12515. PMid:24989897.m
23. Lee HS, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY. Risk factors for re-recurrence after first reoperative surgery for locoregional recurrent/persistent papillary thyroid carcinoma. World J Surg. 2015;39(8):1943-50. http://dx.doi.org/10.1007/s00268-015-3052-2. PMid:25820911.m
24. Tannouri SS, Goldenberg D. Recurrent differentiated thyroid cancer. J Current Surg. 2012;2(3):73-80.m
25. Rosário PW, Cardoso D, Fagundes A, Barroso L, Padrão L, Rezende L, Purisch S. Revisitando a tireoglobulina sérica no seguimento de pacientes com carcinoma diferenciado de tireóide. Arq Bras Endocrinol Metabol. 2004;48(4):480-6. http://dx.doi.org/10.1590/S0004-27302004000400007. PMid:15761510.m
26. Bellotti C, Castagnola G, Tierno SM, Centanini F, Sparagna A, Vetrone I, Mezzetti G. Radioguided surgery with combined use of gamma probe and hand-held gamma camera for treatment of papillary thyroid cancer locoregional recurrences: a preliminary study. Eur Rev Med Pharmacol Sci. 2013;17(24):3362-6. PMid:24379068.m
27. Morais LO, Vieira GCF, Botelho ACLM, Lacerda EA, Nunes EJG, Silva LP, Barbosa MH, Mascarenhas BG, Mascarenhas FG, Matos KLA, Cavalcante CC, Potros FR, Santiago MCF, Braga ACC. Nódulos tireoidianos – uma abordagem diagnóstica. REAS/EJCH. 2019;23:1-7. https://doi.org/10.25248/reas.e402.2019.
Submitted date:
05/14/2020
Accepted date:
05/23/2020
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email